The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site

J Biol Chem. 2013 Aug 16;288(33):24223-33. doi: 10.1074/jbc.M113.451286. Epub 2013 Jun 18.

Abstract

Botulinum neurotoxins are the most toxic of all compounds. The toxicity is related to a poor zinc endopeptidase activity located in a 50-kDa domain known as light chain (Lc) of the toxin. The C-terminal tail of Lc is not visible in any of the currently available x-ray structures, and it has no known function but undergoes autocatalytic truncations during purification and storage. By synthesizing C-terminal peptides of various lengths, in this study, we have shown that these peptides competitively inhibit the normal catalytic activity of Lc of serotype A (LcA) and have defined the length of the mature LcA to consist of the first 444 residues. Two catalytically inactive mutants also inhibited LcA activity. Our results suggested that the C terminus of LcA might interact at or near its own active site. By using synthetic C-terminal peptides from LcB, LcC1, LcD, LcE, and LcF and their respective substrate peptides, we have shown that the inhibition of activity is specific only for LcA. Although a potent inhibitor with a Ki of 4.5 μm, the largest of our LcA C-terminal peptides stimulated LcA activity when added at near-stoichiometric concentration to three versions of LcA differing in their C-terminal lengths. The result suggested a product removal role of the LcA C terminus. This suggestion is supported by a weak but specific interaction determined by isothermal titration calorimetry between an LcA C-terminal peptide and N-terminal product from a peptide substrate of LcA. Our results also underscore the importance of using a mature LcA as an inhibitor screening target.

Keywords: Botulinum Toxin; C Terminus; Enzyme Mechanisms; Enzyme Structure; Metalloprotease; Neurotoxin; Peptide Interactions; Protein Chemistry; Zinc Endopeptidase.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Biocatalysis / drug effects
  • Botulinum Toxins, Type A / antagonists & inhibitors
  • Botulinum Toxins, Type A / chemistry*
  • Botulinum Toxins, Type A / metabolism*
  • Calorimetry
  • Catalytic Domain*
  • Clostridium botulinum / classification
  • Clostridium botulinum / metabolism*
  • Enzyme Stability / drug effects
  • Kinetics
  • Models, Molecular
  • Molecular Sequence Data
  • Mutant Proteins / chemistry
  • Mutant Proteins / metabolism
  • Neurotoxins / chemistry*
  • Neurotoxins / metabolism*
  • Peptides / chemistry
  • Peptides / pharmacology
  • Protein Binding / drug effects
  • Protein Structure, Secondary
  • Protein Unfolding / drug effects
  • Serotyping
  • Structure-Activity Relationship
  • Substrate Specificity / drug effects
  • Synaptosomal-Associated Protein 25 / metabolism
  • Temperature

Substances

  • Mutant Proteins
  • Neurotoxins
  • Peptides
  • Synaptosomal-Associated Protein 25
  • Botulinum Toxins, Type A